-
441
-
442
Hepatocyte-derived liver progenitor-like cells attenuate liver cirrhosis via induction of apoptosis in hepatic stellate cells
Published 2025-02-01“…Background:. Cell therapy demonstrates promising potential as a substitute therapeutic approach for liver cirrhosis. …”
Get full text
Article -
443
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
Published 2024-08-01Get full text
Article -
444
Stem Cells and Platelet-Rich Plasma Enhance the Healing Process of Tendinitis in Mice
Published 2019-01-01“…Currently, there is no evidence on the best treatment for these pathologies. Cell therapy has been studied in several animal models, and encouraging results have been observed with respect to tissue regeneration. …”
Get full text
Article -
445
Regeneration of Tracheal Tissue in Partial Defects Using Porcine Small Intestinal Submucosa
Published 2018-01-01Get full text
Article -
446
Lyophilized human platelet lysate: manufacturing, quality control, and application
Published 2025-01-01“…Human platelet lysate (HPL), derived from expired PCs, has gained attention as an ethical and sustainable cell culture media supplement in biomedical research and cell therapy production. However, HPL is subject to decisive disadvantages such as batch differences and lack of storage stability. …”
Get full text
Article -
447
CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors
Published 2025-02-01“…Background Responsiveness to chimeric antigen receptor (CAR) T cell therapy correlates with CAR T cell expansion and persistence in vivo. …”
Get full text
Article -
448
-
449
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue
Published 2025-01-01Get full text
Article -
450
Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils
Published 2025-02-01“…These results provide a theoretical basis for a deeper understanding of the mechanisms of stem cell therapy and for exploring suitable delivery pathways of stem cell treatment.…”
Get full text
Article -
451
-
452
The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells
Published 2025-02-01“…Overall, the molecular receptor NKBB significantly increased the persistence of GPC3 CAR-T cells, and GC3328z-NKBB CAR-T cells possessed potent anti-HCC activity in mice, providing a new strategy for the potential improvement of adoptive T cell therapy in the treatment of HCC.…”
Get full text
Article -
453
Adoptive cell transfer of piezo-activated macrophage rescues immunosuppressed rodents from life-threating bacterial infections
Published 2025-02-01“…Moreover, we test the use of these piezo-activated macrophages (piezoMϕ) as adoptive cell therapy (ACT) for treating various immunosuppressive bacterial infections, including sepsis, pneumonia and peritonitis. …”
Get full text
Article -
454
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
Published 2025-01-01“…Our findings indicate that depleting SRSF1 in CD8+ T cells improve antitumor immune function, glycolytic metabolism, and the efficacy of adoptive T cell therapy. The inactivation of SRSF1 in tumor cells reduces transcription factors, including c-Jun, c-myc, and JunB, facilitating glycolytic metabolism reprogramming, which restores CD8+ T cell function and inhibits tumor growth. …”
Get full text
Article -
455
Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Published 2022-01-01“…Background Adoptive transfer of CD19-specific chimeric antigen receptor (CD19CAR) T cells can induce dramatic disease regression in patients with B cell malignancies. CD19CAR T cell therapy may be limited by insufficient engraftment and persistence, resulting in tumor relapse. …”
Get full text
Article -
456
-
457
MicroRNAs Expression Profile in MN1-Altered Astroblastoma
Published 2025-01-01Get full text
Article -
458
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach
Published 2025-01-01“…Chimeric antigen receptor (CAR) T-cell therapy targeting BCMA has shown efficacy in relapsed or refractory MM, but it faces resistance due to antigen loss and the tumor microenvironment. …”
Get full text
Article -
459
-
460
ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2
Published 2025-01-01“…Emerging therapies, such as chimeric antigen receptor (CAR)-T cell therapy, have shown promise but face significant challenges in targeting solid tumors. …”
Get full text
Article